Search Results 1501-1510 of 20516 for hepatitis

1. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   Known or suspected human immunodeficiency virus (HIV), hepatitis B virus (HBV), and/or hepatitis C virus (HCV) infections. Emergency surgery in the previous ...

2. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

   Autoimmune hepatitis (AIH) indicative of PBC with overlap syndrome. Note ... Moderate to severe interface hepatitis on histology. 5. Hemochromatosis. 6 ...

3. Publications - Mauricio A. Villavicencio, M.D., M.B.A. - Mayo Clinic

   Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response. JTCVS Open. 2023 Jun; 14 ...

4. A Study to Evaluate the Safety of Acamprosate for Alcohol Use Disorder - Mayo Clinic

   ... hepatitis, compatible clinical, imaging and laboratory findings and typical histology on liver biopsy, if performed. Underlying liver disease may include ...

5. Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

   Known hepatitis B, hepatitis C or HIV infection. Subjects with a history of TEE such as deep vein thrombosis, pulmonary embolism, myocardial infarction ...

6. A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4) - Mayo Clinic

   Subject is seropositive for human immunodeficiency virus, chronic or active hepatitis B or active hepatitis A or C. Participating Mayo Clinic locations.

7. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

   Any positive test for hepatitis B virus or hepatitis C virus indicating acute or chronic infection; Known history of testing positive for Human ...

8. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

   Have negative serology for hepatitis B virus (HBV) and hepatitis C virus (HCV). Exclusion Criteria: Had a prior liver transplant or is planned to undergo ...

9. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

   ... hepatitis, Autoimmune hepatitis, Amyloidosis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Budd-Chiari syndrome ...

10. Clinical Trials - IS-002 in Prostate Cancer

    Subject has known active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. 3. Subject has a known history of acute or chronic liver or kidney ...